Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00474357
Other study ID # LH55/2007.CTIL
Secondary ID
Status Recruiting
Phase N/A
First received May 15, 2007
Last updated December 16, 2010
Start date May 2007
Est. completion date October 2008

Study information

Verified date May 2008
Source Lev-Hasharon Mental Healtlh Center
Contact Deby Peres, MD
Phone +972-9-8981242
Email debyp@lev-hasharon.co.il
Is FDA regulated No
Health authority Israel: Israeli Health Ministry Pharmaceutical Administration
Study type Interventional

Clinical Trial Summary

This study will examine:

1) The impact of psycho education group therapy sessions relating to beliefs/myths associated with bipolar affective disorder (BAD) on the emotional wellbeing, clinical course and cognition of individuals diagnosed with BAD 2) Will examine the existence of those same beliefs among the various caregivers - psychiatrists, general practitioners, social workers, and psychiatric nurses.

The investigators hypothesize that psychoeducation group therapy will be effective in refuting the myths and will lead to better treatment adherence, longer remissions, fewer hospitalizations, improved self esteem, increased optimism, and better control over the disease process. The investigators also believe that they will identify some beliefs/myths or preconceived notions that are common to both caregivers and individuals with BAD.


Description:

Methods:

Effect psychoeducation:

Study population - 30 patients diagnosed with BAD treated in the outpatient clinic, in a state of remission will be evaluated with the Hamilton Rating Scale for Depression, Young Mania Rating Scale, and will then participate in 7 weekly sessions of brief structured psycho education therapy Control group - 30 patients diagnosed with BAD treated in the outpatient clinic, in a state of remission will be evaluated with the Hamilton Rating Scale for Depression, Young Mania Rating Scale. In addition both groups will complete the Snyder Hope Scale, Accepting the Mental Illness Label Scale and a questionnaire regarding Myths in BAD prior to the study, and when the study group finishes their group therapy sessions. (Controls will not participate in the psychoeducation group therapy).

Caregivers beliefs:

50 caregivers from various professions will complete the questionnaire regarding the myths, once only.


Recruitment information / eligibility

Status Recruiting
Enrollment 110
Est. completion date October 2008
Est. primary completion date October 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- DSM-IV diagnosis of BAD

- State of remission

Exclusion Criteria:

- HAM-D score < 10

- YMRS score < 12

- Has a guardian for either self or property

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Intervention

Behavioral:
Brief Structured Psychoeducation Group Therapy
weekly brief structured psychoeducation group therapy for seven weeks for bipolar patients

Locations

Country Name City State
Israel Lev Hasharon Mental Health Center Netanya

Sponsors (1)

Lead Sponsor Collaborator
Lev-Hasharon Mental Healtlh Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accepting Mental Illness Scale 7 weeks No
Secondary Hope Scale 7 weeks No
Secondary Myths about BAD questionnaire 7 weeks No
See also
  Status Clinical Trial Phase
Completed NCT03275714 - Evaluation of an App for Smartphones for People With a Bipolar Affective Disorder N/A
Completed NCT03249857 - Study of Sensorimotor Compatibility Effects in Bipolar Affective Disorder. N/A
Completed NCT01722344 - Improving Work Outcome for People With Severe Mental Illness N/A
Completed NCT01431092 - Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia Phase 4
Completed NCT01315028 - Bipolar Intervention Study: Cognitive Interpersonal Therapy N/A
Terminated NCT00805493 - Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder Phase 2
Completed NCT00436020 - rTMS in the Treatment of Bipolar Depression N/A
Withdrawn NCT00397605 - Cannabinoids in Bipolar Affective Disorder N/A
Recruiting NCT05860101 - Compassion-Focused Therapy for Distressing Mood Swings: A Case Series N/A
Recruiting NCT06176456 - Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia N/A
Terminated NCT03310593 - Cannabidiol as an Adjunctive Treatment for Bipolar Depression Phase 2/Phase 3
Recruiting NCT05406414 - The Efficacy of a Transdiagnostic Sleep and Circadian Intervention for Patients With Mental Disorders and Sleep Problems N/A
Completed NCT02773108 - Somatic Comorbidities in Psychiatric Patients
Withdrawn NCT00327756 - Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder Phase 2
Completed NCT02453217 - The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial N/A
Completed NCT05683431 - Using Neuroplasticity-Based Computerized Training to Improve Emotion Regulation in Bipolar Disorder (BRAINS) N/A
Not yet recruiting NCT05915312 - Exosome for Early Diagnosis of Bipolar Affective Disorder
Completed NCT00186758 - Transcranial Magnetic Stimulation in Bipolar Depression Phase 4
Completed NCT02083978 - Bipolar Research Study Using MR Imaging N/A
Completed NCT00683709 - Specialized Clozapine Clinic for Bipolar and Schizoaffective Disorder Phase 4